Abstract
We thank Dr. Riddle for addressing his concerns regarding the potential methodological issues. First, this article (1) has been prepared in compliance with the CONSORT statement (2), including all pre-specified evaluation methods and results and, therefore, there is no concern regarding selective outcome reporting. Diclofenac hyaluronate (DF-HA) is a developmental product and has never been on the market in any country.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
